Cohance Lifesciences announces resignation of CEO
(28 Jul 2025)

Back
Cohance Lifesciences announced the resignation of Dr. Sudhir Kumar Singh, who looks after the CDMO business, as Chief Executive Officer of the Company with effect from 31 July 2025.

Copyright © 2024 Arihant Capital Markets Ltd. All rights Reserved.

Designed,Developed and Content powered by CMOTS Infotech (ISO 9001:2015 certified)

x
  • QR-CodeNew